German vaccine regulators have confirmed that biotech firm CureVac will begin trialing a coronavirus vaccine on humans. The vaccine could be on market by mid-2021.
Full ArticleWhile most of the global population is under lockdown to prevent the spread of the coronavirus, many laboratories in the pharma..
The second company to launch human trials of an experimental coronavirus vaccine in the country
Unlisted biotech firm CureVac, which is due to receive German state backing, will become the second coronavirus vaccine developer..